Cencora (COR) financial statements

Healthcare · Medical Distribution · Market cap $63.5B

Cencora reported revenue of $321.3B in fiscal 2025, up 9.1% a year over 9 years.

Net income was $1.6B and the operating margin 0.8%, against 1.0% in 2016.

Free cash flow was $3.2B, and the company returned $437M in dividends and $435M in net buybacks.

The diluted share count fell 14% over the period (buybacks).

Revenue and free cash flow

Fiscal years, $ billions.

01002003004002016201720182019202020212022202320242025RevenueFree cash flow
Embed this chart

Free to use in articles and newsletters with the source line. Paste this HTML:

Income statement

Fiscal years, from Cencora's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Revenue$146.8B$153.1B$167.9B$179.6B$189.9B$214.0B$238.6B$262.2B$294.0B$321.3B
Cost of revenue$142.6B$148.6B$163.3B$174.5B$184.7B$207.0B$230.3B$253.2B$284.0B$309.9B
Gross profit$4.3B$4.5B$4.6B$5.1B$5.2B$6.9B$8.3B$9.0B$9.9B$11.5B
Selling, general and admin$2.1B$2.1B$2.5B$2.7B$2.8B$3.6B$4.8B$5.3B$5.7B$6.5B
Operating income$1.5B$1.1B$1.4B$1.1B-$5.1B$2.4B$2.4B$2.3B$2.2B$2.6B
Pre-tax income$1.4B$918M$1.2B$967M-$5.3B$2.2B$2.2B$2.2B$2.0B$2.3B
Income tax-$37M$553M-$438M$113M-$1.9B$677M$517M$428M$485M$691M
Net income$1.4B$364M$1.7B$855M-$3.4B$1.5B$1.7B$1.7B$1.5B$1.6B
EPS (diluted)$6.32$1.64$7.53$4.04-$16.65$7.39$8.04$8.53$7.53$7.96
Diluted shares226M222M220M212M205M208M211M205M200M195M
Gross margin2.9%3.0%2.7%2.9%2.7%3.2%3.5%3.4%3.4%3.6%
Operating margin1.0%0.7%0.9%0.6%-2.7%1.1%1.0%0.9%0.7%0.8%
Net margin1.0%0.2%1.0%0.5%-1.8%0.7%0.7%0.7%0.5%0.5%

Balance sheet

Fiscal years, from Cencora's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Cash and short-term investments$2.7B$2.4B$2.5B$3.4B$4.6B$2.5B$3.4B$2.6B$3.1B$4.4B
Receivables$9.2B$10.3B$11.3B$12.4B$13.8B$18.2B$18.5B$20.9B$23.9B$25.2B
Inventory$10.7B$11.5B$11.9B$11.1B$12.6B$15.4B$15.6B$17.5B$19.0B$20.5B
Total current assets$22.9B$24.3B$25.9B$28.1B$33.1B$38.8B$39.6B$42.8B$47.7B$52.2B
Property, plant and equipment$1.5B$1.8B$1.9B$1.8B$1.5B$2.2B$2.1B$2.1B$2.2B$2.5B
Goodwill$6.0B$6.0B$6.7B$6.7B$6.7B$9.0B$8.5B$9.6B$9.3B$13.7B
Total assets$33.6B$35.3B$37.7B$39.2B$44.3B$57.3B$56.6B$62.6B$67.1B$76.6B
Total current liabilities$25.3B$26.8B$27.9B$29.6B$33.9B$41.4B$43.5B$48.8B$54.3B$57.8B
Long-term debt$3.6B$3.4B$4.2B$4.0B$3.6B$6.4B$4.6B$4.1B$3.8B$7.5B
Total liabilities$31.5B$33.3B$34.6B$36.2B$45.1B$56.8B$56.5B$61.9B$66.3B$74.8B
Shareholders' equity$2.1B$2.1B$2.9B$2.9B-$1.0B$223M-$212M$522M$646M$1.5B
Net debt$1.4B$1.0B$1.8B$799M-$478M$4.1B$2.3B$2.2B$1.3B$3.3B

Cash flow

Fiscal years, from Cencora's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Operating cash flow$3.2B$1.5B$1.4B$2.3B$2.2B$2.7B$2.7B$3.9B$3.5B$3.9B
Capital spending$465M$466M$336M$310M$370M$438M$496M$458M$487M$668M
Free cash flow$2.7B$1.0B$1.1B$2.0B$1.8B$2.2B$2.2B$3.5B$3.0B$3.2B
Stock-based compensation$65M$62M$62M$59M$74M$100M$93M$125M$148M$148M
Dividends paid$288M$320M$333M$339M$344M$367M$392M$399M$416M$437M
Share buybacks (net)-$2.3B-$330M-$639M-$674M-$420M-$82M-$484M-$1.2B-$1.5B-$435M
Net borrowing$200M-$750M$633M-$4M$1M$2.3B$155M-$654M$26M$3.2B
Free cash flow margin1.8%0.7%0.6%1.1%1.0%1.0%0.9%1.3%1.0%1.0%
Dividends per share$1.28$1.45$1.51$1.60$1.68$1.76$1.85$1.95$2.08$2.24
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for COR.
Open COR in Investingly

Questions

What was Cencora's revenue in 2025?

$321.3B in fiscal 2025, from its 10-K filing.

How much free cash flow does Cencora generate?

$3.2B in fiscal 2025 (operating cash flow minus capital spending).

From Cencora's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.